Cargando…
Functional imaging in combination with mutation status aids prediction of response to inhibiting B-cell receptor signaling in lymphoma
Aberrant B-cell receptor (BCR) signaling is known to contribute to malignant transformation. Two small molecule inhibitors targeting BCR pathway signaling include ibrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor, and idelalisib, a specific Phosphatidylinositol-4,5-bisphosphate 3-kinase delta (P...
Autores principales: | Jacobs, Laura, Habringer, Stefan, Slawska, Jolanta, Huber, Katharina, Hauf, Elke, Li, Zhoulei, Refaeli, Yosef, Schwaiger, Markus, Rudelius, Martina, Walch, Axel, Keller, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668008/ https://www.ncbi.nlm.nih.gov/pubmed/29108275 http://dx.doi.org/10.18632/oncotarget.20551 |
Ejemplares similares
-
Positron emission tomographic monitoring of dual phosphatidylinositol-3-kinase and mTOR inhibition in anaplastic large cell lymphoma
por: Graf, Nicolas, et al.
Publicado: (2014) -
An adult patient with Nijmegen Breakage Syndrome and Hodgkin's Lymphoma
por: Engel, Katharina, et al.
Publicado: (2014) -
Response assessment with the CXCR4-directed positron emission tomography tracer [(68)Ga]Pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavities
por: Herhaus, Peter, et al.
Publicado: (2017) -
USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B‐cell lymphoma
por: Engel, Katharina, et al.
Publicado: (2016) -
MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma
por: Stroh, Jacob, et al.
Publicado: (2022)